Prosper Stars & Stripes released its Q2 2025 investor letter, showing a net return of +9.6%, underperforming the Russell 2000 Index and the HFRX Equity Hedge Index. The portfolio demonstrated strong outperformance relative to its net exposure. US equities rebounded in Q2. Check out the fund’s top five holdings for 2025’s best picks.

Bio-Rad Laboratories, Inc. (NYSE:BIO) was highlighted in Prosper Stars & Stripes’ Q2 2025 letter. The medical device company’s one-month return was 7.62%, with shares losing 11.69% over 52 weeks. On August 29, 2025, BIO closed at $297.88 per share, with a market cap of $7.858 billion. The fund sees promise in BIO’s bioprocessing sector.

Bio-Rad Laboratories, Inc. (NYSE:BIO) is not among the 30 most popular stocks among hedge funds. 42 hedge fund portfolios held BIO at the end of Q2, up from 36 in the previous quarter. While BIO has potential, the fund believes certain AI stocks offer greater upside with less downside risk. Explore a report on the best short-term AI stock.

Read more at Yahoo Finance: Is Bio-Rad Laboratories (BIO) Entering a Period of More Sustained Recovery?